To deal with relapsed or refractory diffuse huge B-mobile lymphoma (not if not specified) and superior-grade B-mobile lymphoma right after two or even more strains of systemic therapyThe donanemab demo experienced better charges of swelling and bleeding as opposed to Leqembi demo, but comparisons are tricky due to dissimilarities in individuals and